ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q3 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,105,035 | +6.0% | 75,153 | +18.4% | 0.00% | +100.0% |
| Q2 2023 | $1,986,142 | -0.5% | 63,455 | -10.4% | 0.00% | 0.0% |
| Q1 2023 | $1,997,064 | -4.3% | 70,843 | -11.3% | 0.00% | -50.0% |
| Q4 2022 | $2,086,324 | +25.7% | 79,844 | +7.4% | 0.00% | +100.0% |
| Q3 2022 | $1,660,000 | -61.8% | 74,345 | -49.0% | 0.00% | -66.7% |
| Q2 2022 | $4,342,000 | -18.5% | 145,746 | -28.0% | 0.00% | 0.0% |
| Q1 2022 | $5,328,000 | -17.5% | 202,505 | -27.1% | 0.00% | -25.0% |
| Q4 2021 | $6,458,000 | -23.9% | 277,657 | +0.9% | 0.00% | -33.3% |
| Q3 2021 | $8,487,000 | +29.7% | 275,195 | +3.1% | 0.01% | +50.0% |
| Q2 2021 | $6,546,000 | +34.6% | 266,981 | +2.5% | 0.00% | +33.3% |
| Q1 2021 | $4,863,000 | +8.1% | 260,348 | +15.4% | 0.00% | 0.0% |
| Q4 2020 | $4,500,000 | -3.2% | 225,561 | -19.6% | 0.00% | -25.0% |
| Q3 2020 | $4,649,000 | +38.5% | 280,581 | +62.2% | 0.00% | +33.3% |
| Q2 2020 | $3,356,000 | +478.6% | 172,954 | +330.0% | 0.00% | +200.0% |
| Q1 2020 | $580,000 | -21.1% | 40,221 | +11.6% | 0.00% | 0.0% |
| Q4 2019 | $735,000 | +1.4% | 36,030 | -3.0% | 0.00% | 0.0% |
| Q3 2019 | $725,000 | -13.3% | 37,145 | +0.1% | 0.00% | 0.0% |
| Q2 2019 | $836,000 | -45.4% | 37,097 | -11.5% | 0.00% | 0.0% |
| Q1 2019 | $1,530,000 | +33.0% | 41,927 | +7.7% | 0.00% | 0.0% |
| Q4 2018 | $1,150,000 | -40.8% | 38,943 | -14.9% | 0.00% | -50.0% |
| Q3 2018 | $1,941,000 | +7.3% | 45,735 | +4.1% | 0.00% | 0.0% |
| Q2 2018 | $1,809,000 | -34.6% | 43,935 | -7.9% | 0.00% | -33.3% |
| Q1 2018 | $2,764,000 | +11.1% | 47,703 | +5.0% | 0.00% | +50.0% |
| Q4 2017 | $2,487,000 | +132.6% | 45,439 | +116.1% | 0.00% | +100.0% |
| Q3 2017 | $1,069,000 | -30.3% | 21,026 | -20.5% | 0.00% | -50.0% |
| Q2 2017 | $1,534,000 | -12.2% | 26,464 | -11.4% | 0.00% | 0.0% |
| Q1 2017 | $1,748,000 | +2.3% | 29,880 | -2.8% | 0.00% | 0.0% |
| Q4 2016 | $1,708,000 | +1.1% | 30,732 | -14.5% | 0.00% | 0.0% |
| Q3 2016 | $1,690,000 | +23.6% | 35,938 | +13.6% | 0.00% | 0.0% |
| Q2 2016 | $1,367,000 | +47.3% | 31,640 | +16.6% | 0.00% | +100.0% |
| Q1 2016 | $928,000 | -56.9% | 27,144 | +0.1% | 0.00% | -66.7% |
| Q4 2015 | $2,152,000 | +36.3% | 27,107 | +0.7% | 0.00% | +50.0% |
| Q3 2015 | $1,579,000 | +129.5% | 26,911 | +151.8% | 0.00% | +100.0% |
| Q2 2015 | $688,000 | +14.3% | 10,689 | +8.2% | 0.00% | 0.0% |
| Q1 2015 | $602,000 | -9.6% | 9,879 | -13.2% | 0.00% | 0.0% |
| Q4 2014 | $666,000 | +36.5% | 11,380 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $488,000 | -21.0% | 11,380 | -7.4% | 0.00% | 0.0% |
| Q2 2014 | $618,000 | +22.6% | 12,284 | +7.5% | 0.00% | 0.0% |
| Q1 2014 | $504,000 | -43.3% | 11,425 | -47.7% | 0.00% | -50.0% |
| Q4 2013 | $889,000 | -54.8% | 21,853 | -62.6% | 0.00% | -50.0% |
| Q3 2013 | $1,965,000 | -71.5% | 58,450 | -75.7% | 0.00% | -73.3% |
| Q2 2013 | $6,886,000 | – | 240,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |